Researchers at Harvard University and the Wyss Institute are developing an injectable biomaterial that forms a tiny scaffold in the body which can be used to re-program cells and trigger an immune response to fight cancer and infectious diseases. Ben Gruber Reports.
02:35
02:13
01:58
01:32
02:08
01:36
02:17
02:38
02:30
01:13
02:09
02:09
02:10
01:57
01:34
02:48
02:10
04:15
02:02
01:20